Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Giovanni Di Perri and Massimo Andreoni.
Giovanni Di Perri
Connection Strength
0.955
Massimo Andreoni
  1. Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks' Glecaprevir/Pibrentasvir Therapy. Infect Dis Ther. 2021 Jun; 10(2):763-774.
    View in: PubMed
    Score: 0.233
  2. Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment. New Microbiol. 2018 Apr; 41(2):112-117.
    View in: PubMed
    Score: 0.190
  3. Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients. PLoS One. 2018; 13(2):e0192627.
    View in: PubMed
    Score: 0.189
  4. Current and future challenges in HCV: insights from an Italian experts panel. Infection. 2018 Apr; 46(2):147-163.
    View in: PubMed
    Score: 0.185
  5. Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT). Clin Microbiol Infect. 2021 Mar; 27(3):389-395.
    View in: PubMed
    Score: 0.058
  6. Real life experiences in HCV management in 2018. Expert Rev Anti Infect Ther. 2019 02; 17(2):117-128.
    View in: PubMed
    Score: 0.050
  7. Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. New Microbiol. 2018 10; 41(4):247-255.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.